Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HRS-8427 for hospital-acquired and ventilator-associated bacterial pneumonia
CTR20250599Phase 2Active
- Sponsor
- Hengrui Therapeutics
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-8427 in hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), sponsored by Hengrui Therapeutics. Started Apr 2025; status: active.
02
Drugs
HRS-8427
03
Conditions
hospital-acquired pneumonia (HAP)ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on CTR20250599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250599.